1/14/2017 weekend several biotechs update

Although these following biotech stocks are not in my portfolios yet(some were in my portfolios before, but not now, since I am changing to invest/trade more on ETfs), they are pretty popular in the investment community. I am not very familiar with fundamentals of these biotech companies. Here I am concentrating on the technical outlook. First let's look at Lexicon Pharmaceuticals (LXRX). Both daily chart and weekly are posted following. Daily charts showed very positive trading flow. All technical indicators point up. Short term price is expected to go up. The top trend line should be challenged.  Weekly chart is still neutral. Next several weeks or months, the price mostly runs within a big triangle. There will be a break out or break down next several months. My personal bias is break out. However, the break down case is prepared for strong strong buy.

http://schrts.co/yLHz6Y

http://schrts.co/ZAsaVN

Second, let's take a look at Bellicum Pharmaceuticals (BLCM). Within technical indicators: MACD is positive, CCI runs from botom up. RSI slowly moves up(most technical indicators are positive). The only negative thing is all short term MAs point down. So next several days' price action is important, if price move up from here. All short term MAs will revers up to turn into support.Level strong support is at around 13, level strong resistance is at around 16, short term price may runs between these 2 levels until a break out/down. My personal opinions is relatively neutral. 

  

http://schrts.co/6N58iI

Last one is Array Biopharma (ARRY). The weekly showed as following. The stock price enjoyed a monster run recently. The long term top break out is huge for potentially much higher price. The measured move target is 8.5-2.5+8.5= 14.5. As long as 8.5 strong support hold, upside target is still possible. So buy level is around 8.5. break back down 8.5, long should bail out, and no immediate buy.

http://schrts.co/erzVjF

In summary, the individual biotech stock is very volatile due to the trial data or FDA news, etc. The technical analysis is helping to identify where the stock could be a buy entry or a sell target. Investing in a biotech stock should keep right size of position and right time frame to hold. Personally, I may like to trade/hold LXRX, trade ARRY only within these 3.